Stock Losses

Biogen (BIIB) TECFIDERA Securities Fraud Class Action Lawsuit

This lawsuit alleges that, during the first half of 2015, Biogen purposefully overstated its future revenue growth, based largely on expectations for its flagship drug TECFIDERA, and that the overstated forecast artificially inflated the Biogen stock price.  Read more

Plains All American Pipeline (PAA) Securities Fraud Class Action

This securities fraud class action alleges that Plains All American Pipeline issued false and misleading statements concerning its pipeline monitoring, maintenance and spill response measures, as well as its compliance with federal regulations governing its pipeline operations.  Read more

Resource Capital (RSO) Securities Fraud Class Action Lawsuit

This securities fraud class action alleges that Resource Capital should have disclosed its exposure to the Puerto Rican economy sooner than it did and therefore the REIT was trading at an artificially inflated value.  Read more

Abengoa (ABGB) Securities Fraud Class action Lawsuit

This lawsuit alleges that since November 12, 2014, Abengoa has misrepresented the liquidity of  its balance sheet in corporate reports filed with the SEC and in conference calls with financial analysts.   Read more

Trinet Group (TNET) Securities Fraud Class Action Lawsuit

This lawsuit alleges Trinet misrepresented to investors the accurate costs associated with workers compensation claims.  Specifically, that the company was experiencing greater than announced worker compensation costs even after analysts queried executives about the lower-than-industry average cost projections.  Read more

AAC Holdings (AAC) Securities Fraud Class action Lawsuit

This lawsuit alleges that AAC Holdings and its CEO failed to disclose to investors that the company, the CEO, and other employees were under criminal investigation for murder in connection with the operation of its facilities.  Read more

Northwest Biotherapuetics (NWBO) Securities Fraud Class Action Lawsuit

This securities class action alleges that executives at Northwest Biotherapeutics overstated or misstated results from ongoing clinical trials of certain therapies and engaged in an undisclosed stock promotion campaign to artificially inflate the company's stock price.  Read more

MaxPoint Interactive (MXPT) Securities Fraud Class action Lawsuit

This securities fraud lawsuit alleges that MaxPoint Interactive failed to properly disclose to investors during its IPO that most of its business was concentrated in less than 50 customers subjecting MaxPoint Interactive to undisclosed customer budget constraints.  MaxPoint has lost 60% of its value since the IPO in March, 2015.  Read more

El Pollo Loco (LOCO) Securities Fraud Class Action Suit

This lawsuit alleges that executives at El Pollo Loco hid from investors the negative impact of rising labor and food costs and the decrease in same store traffic so that insiders could sell millions of dollars of stock at artificially inflated prices.  Read more

CaesarStone (CSTE) Securities Fraud CLass Action Lawsuit

     This securities fraud class action alleges that CaesarStone  failed to disclose a whole series of negative news developments to investors in real time and in fact purposely kept the news from them.  Read more